Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome
GET TICKETS

Benzinga's Biggest Movers For The Week Of May 14, 2018

Share:

The data presented below was compiled using a Screener widget and a Newsfeed widget on the Benzinga Pro platform. The Screener is customizable and is available for the pre-market and after-hours sessions in addition the the intraday session. To try out these widgets, sign up for a trial of the Benzinga Pro platform.

Percentage changes in prices below refer to total weekly change.

Biggest Gainers

  • Seadrill Ltd (NYSE: SDRL) - Gained 89.7 percent on high trading volume despite no company-specific or fundamental news.
  • ADOMANI Inc (NASDAQ: ADOM) - Gained 83.4 percent on Friday alone; No formal news regarding the company.
  • VIVUS Inc (NASDAQ: VVUS) - Shares up 48.8 percent for the week after the company received letter from Nasdaq regarding continued listing subject to certain conditions; The company must have effected reverse stock split, evidenced closing bid by October 1.
  • VAALCO Energy Inc (NYSE: EGY) - Up 40.7 percent in sympathy with other energy and petroleum stocks after Thursday news of oil rebound.
  • Black Box Corp (NASDAQ: BBOX) - Up 39.2 percent despite no company-specific news.

Biggest Losers

  • Agile Therapeutics Inc (NASDAQ: AGRX) - Down 75 percent after the FDA on Friday announced significant concerns regarding the company’s Twirla contraceptive.
  • Cesca Therapeutics Inc (NASDAQ: KOOL) - Down 52.8 percent. The company on Monday reported Q1 EPS and Sales down YoY, and on Wednesday priced a ~9.2 million share offering at 60 cents per share. With ~11.5 million shares outstanding, it could also be attracting low-float interest.
  • Netshoes (Cayman) Ltd (NYSE: NETS) - Down 48.8 percent. The company reported a Q1 earnings miss on Monday and was downgraded by JPMorgan on Wednesday.
  • ATyr Pharma Inc (NASDAQ: LIFE) - Down 39.8 percent. The company on Monday reported a Q1 miss and announced it would undergo a restructuring, including a 30-percent workforce reduction.
  • Jounce Therapeutics Inc (NASDAQ: JNCE) - Down 34.9 percent after a ASCO abstract released Wednesday. Abstract showed the company’s JTX-2011 0.3mg/kg had 'no substantial change in number of peripheral Teff or Tregs'.

Posted-In: News After-Hours Center Movers Trading Ideas

 

Related Articles (AGRX + ADOM)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

5 Analysts On Q1 Retail Earnings

Credit Suisse Buying In On Marriott's Timeshare Business